78 results
Page 2 of 4
424B3
s433jmx gg3
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
z6o knseovode61nl1
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
utlrfpmudm0yqsc
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.1
2vu8 fb3s1
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
kkjlw20p637d3hx4
7 May 21
Business combination disclosure
7:08am
DEF 14A
g8651fa3ejrsyje
9 Sep 20
Definitive proxy
4:00pm
10-Q
7jjpc rx3y
13 Aug 20
Quarterly report
8:30am
PRE 14A
0c09qryh 8xd941sj9
10 Aug 20
Preliminary proxy
12:00am
10-K
h8yojtkscrmryyqvj8d
29 Jun 20
Annual report
4:02pm
S-3
EX-1.2
ur2ftrqje4b4m8eng7
29 Jun 20
Shelf registration
12:00am
6-K
EX-99.1
doqkrwkebbs61k
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
jdgr j40yhvml1tvy
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
i1sp 32w49eb7voe7
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
y1rahdm4wi4ecy2
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
w185yc4r38s5 dj00u
13 Nov 19
Current report (foreign)
7:55am